Cosmos Health 近日就其美国市场产品组合提供了最新进展。公司宣布推出四款全新的“18系列”产品。根据预测,这些新产品的年化收入有望超过2270万美元,并带来大约1700万美元的毛利润。
Cosmos Health 近日就其美国市场产品组合提供了最新进展。公司宣布推出四款全新的“18系列”产品。根据预测,这些新产品的年化收入有望超过2270万美元,并带来大约1700万美元的毛利润。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.